ASGO Research Grants

The aim of ASGO Research Grants are to fund small or pilot projects in any area of gynaecological cancer research undertaken by ASGO Members or their fellows as the principal researcher.

2026 Submissions Open
Submissions for 2026 ASGO grants are open and will close on Friday 28th August at 11.59pm (AEST)

view research grant guidelines
VIEW GRANT CRITERIA
DOWNLOAD ASGO GRANT APPLICATION FORM

If you have any questions please contact the ASGO Secretariat at asgo@yrd.com.au  or +61 7 3368 2422.

Awarded Grants

  • Surgery in Ovarian Cancer - Quality of Life Evaluation Research = The SOCQER oOZ Study

    Vivek Arora

    $20,000

  • The Case for Pre-operative Very Low Calorie Diets (VLCDs) in Obese Endometrial Cancer Patients

    Chloe Ayres

    $12,500

    Testing individual Interventions to optimize Perioperative care in ovarian cancer Surgery (TIPS-Study)

    Alison Brand

    $12,500

  • A Prospective Audit of Sentinel Node Biopsy for Vulval Carcinoma in Australia and New Zealand

    Peter Sykes

    $25,000

  • The Correlation Between Macroscopic Surgical Assessment, Histological and Molecular Subtypes of High Grade Serous Cancer of Fallopian, Ovarian and Peritoneal Origin

    Yale Naaman

    $10,000

  • No grants awarded.

  • feMMe Long Term Follow-Up Study

    Andreas Obermair

    $18,615

  • EBONY - Early Biopsy of Ovarian Cancer Following Neoadjuvant Chemotherapy. A Feasibility Study

    Bryony Simcock

    $28,896

  • Feasibility of Groin Ultrasound to Predict Groin Lymph Node Involvement in Patients with Histologically Proven Vulvar Cancer

    Andreas Obermair

    $29,820

  • The Feasibility and Acceptability of Patient Initiated Follow Up Following Surgical Management of Low Risk Endometrial Endometrioid Adenocarcinoma

    Emma Allanson

    $29,726.25

  • Predictors of REsponse to conSERVATIve management in endOmentral caNcer: The PRESERVATION Study

    Monica McGauran

    $26,550

  • Quality of Life and Adherence to Post-Operative Thromboprophylaxis Following Surgery for Gynaecological Cancers: Rivaroxaban vs Enoxaparin

    Marilyn Boo

    $19,000

    Homologous Recombination Deficiency (HRD) Testing of Ascites in Ovarian Cancer Patients

    Marta Preston

    $16,417.40